![Marc Cluzel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marc Cluzel
Director/Board Member at Moleac Pte Ltd.
Net worth: 635 338 $ as of 2024-05-30
Profile
Marc Cluzel is the founder of C&F Consulting, which was founded in 2011.
He is currently an Independent Director at Moleac Pte Ltd.
and a Director at Griffon Pharmaceuticals, Inc. Dr. Cluzel previously served as the Chairman & Chief Executive Officer of Sanofi-Aventis Recherche et Développement SA from 2002 to 2011.
He also held the position of Chairman-Supervisory Board at MorphoSys AG from 2018 to 2024.
Additionally, Dr. Cluzel was the Executive Vice President-Research & Development at Sanofi from 1991 to 2010 and the Executive Vice President-Product Development at HUYA Bioscience International LLC from 2011 to 2012.
He obtained a doctorate degree from Université de Montpellier in 1990 and another doctorate degree in 1985.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
MORPHOSYS AG
0.02% | 2024-02-15 | 8,525 ( 0.02% ) | 635 338 $ | 2024-05-30 |
Marc Cluzel active positions
Companies | Position | Start |
---|---|---|
Moleac Pte Ltd.
![]() Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore. | Director/Board Member | - |
Griffon Pharmaceuticals, Inc.
![]() Griffon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Griffon Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The private company is based in Montréal, Canada. | Director/Board Member | - |
Former positions of Marc Cluzel
Companies | Position | End |
---|---|---|
MORPHOSYS AG | Chairman | 2024-06-05 |
HUYA Bioscience International LLC
![]() HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 2012-01-01 |
Sanofi-Aventis Recherche et Développement SA
![]() Sanofi-Aventis Recherche et Développement SA Miscellaneous Commercial ServicesCommercial Services Sanofi-Aventis Recherche et Développement SA is a pharmaceutical company based in Chilly-Mazarin, France. Part of Sanofi, Sanofi-Aventis Recherche et Développement SA is a French company that focuses on delivering medicines and vaccines for millions of people around the world. The company's R & D teams work closely with patient communities affected by rare hematological disorders to offer them effective and innovative therapeutic care. Find out more about rare hematological disorders in R&D. The company was founded in 1900. Lionel Joël Bascles has been the CEO of the company since 2018. | Chief Executive Officer | 2010-12-31 |
SANOFI | Chief Tech/Sci/R&D Officer | 2009-12-31 |
C&F Consulting | Founder | - |
Training of Marc Cluzel
Université de Montpellier | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
SANOFI | Health Technology |
MORPHOSYS AG | Health Technology |
Private companies | 5 |
---|---|
HUYA Bioscience International LLC
![]() HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Health Technology |
C&F Consulting | |
Moleac Pte Ltd.
![]() Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore. | Health Technology |
Sanofi-Aventis Recherche et Développement SA
![]() Sanofi-Aventis Recherche et Développement SA Miscellaneous Commercial ServicesCommercial Services Sanofi-Aventis Recherche et Développement SA is a pharmaceutical company based in Chilly-Mazarin, France. Part of Sanofi, Sanofi-Aventis Recherche et Développement SA is a French company that focuses on delivering medicines and vaccines for millions of people around the world. The company's R & D teams work closely with patient communities affected by rare hematological disorders to offer them effective and innovative therapeutic care. Find out more about rare hematological disorders in R&D. The company was founded in 1900. Lionel Joël Bascles has been the CEO of the company since 2018. | Commercial Services |
Griffon Pharmaceuticals, Inc.
![]() Griffon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Griffon Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The private company is based in Montréal, Canada. | Health Technology |
- Stock Market
- Insiders
- Marc Cluzel